AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 17158421 — intervention group
Group type: EXPERIMENTAL
Intervention: Rye bread and pasta (RPa) diet
Number of subjects: 74
Study 17158421 — intervention group
Group type: COMPARATOR
Intervention: Oat, wheat bread, and potato (OWPo) diet
Number of subjects: 74
Study 17158421 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined group
Number of subjects: 74
Study 17158421 — intervention group
Group type: EXPERIMENTAL
Intervention: RPa diet
Number of subjects: 74
Study 15277619 — intervention group
Group type: EXPERIMENTAL
Intervention: PCV (procarbazine, 60 mg/m2 on days 8 to 21; CCNU, 110 mg/m2 on day 1; and vincristine, 1.4 mg/m2 on days 8 and 29)
Number of subjects: 63
Study 15277619 — intervention group
Group type: EXPERIMENTAL
Intervention: Temozolomide (TMZ; 150 to 200 mg/m2 for 5 days every 4 weeks)
Number of subjects: 63
Study 10969645 — intervention group
Group type: EXPERIMENTAL
Intervention: Complete Mediastinal Lymph Node Dissection (MLND)
Number of subjects: 373
Study 10969645 — intervention group
Group type: COMPARATOR
Intervention: Systematic Sampling (SS)
Number of subjects: 373
Study 10969645 — intervention group
Group type: EXPERIMENTAL
Intervention: Complete MLND (right lung tumors)
Number of subjects: 373
Study 10969645 — intervention group
Group type: COMPARATOR
Intervention: Systematic Sampling (right lung tumors)
Number of subjects: 373
Study 9343629 — intervention group
Group type: EXPERIMENTAL
Intervention: Computer-assisted instruction
Number of subjects: 60
Study 9343629 — intervention group
Group type: COMPARATOR
Intervention: Control group (no computer-assisted instruction)
Number of subjects: 60
Study 8445422 — intervention group
Group type: COMPARATOR
Intervention: FEC every 4 weeks
Number of subjects: 173
Study 8445422 — intervention group
Group type: EXPERIMENTAL
Intervention: FEC weekly
Number of subjects: 173
Study 2878131 — intervention group
Group type: EXPERIMENTAL
Intervention: Ileu‐ANP infusion (5 micrograms/min for 4 h)
Number of subjects: 7
Study 2878131 — intervention group
Group type: COMPARATOR
Intervention: Placebo infusion
Number of subjects: 7
Study 29333595 — intervention group
Group type: EXPERIMENTAL
Intervention: Closed-loop gastric electrical stimulation (CLGES) system
Number of subjects: 47
Study 26774608 — intervention group
Group type: EXPERIMENTAL
Intervention: Aliskiren 300 mg per day
Number of subjects: 8561
Study 26774608 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8561
Study 25139724 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrauterine administration of 5 cc of 2% lidocaine
Number of subjects: 67
Study 25139724 — intervention group
Group type: COMPARATOR
Intervention: Paracervical block with saline placebo
Number of subjects: 67
Study 22873367 — intervention group
Group type: EXPERIMENTAL
Intervention: Routine fertility work-up with additional (SIS and) hysteroscopy with on-the-spot treatment of predefined intrauterine abnormalities
Number of subjects: 700
Study 22873367 — intervention group
Group type: COMPARATOR
Intervention: Regular fertility work-up without additional diagnostic tests
Number of subjects: 700
Study 22873367 — intervention group
Group type: EXPERIMENTAL
Intervention: Routine fertility work-up with additional (SIS and) hysteroscopy
Number of subjects: 700
Study 20152247 — intervention group
Group type: EXPERIMENTAL
Intervention: rosuvastatin 10 mg/day
Number of subjects: 16
Study 20152247 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 16
Study 18606919 — intervention group
Group type: COMPARATOR
Intervention: Percutaneous coronary intervention
Number of subjects: 988
Study 18606919 — intervention group
Group type: EXPERIMENTAL
Intervention: Coronary artery bypass grafting (CABG)
Number of subjects: 988
Study 15962392 — intervention group
Group type: EXPERIMENTAL
Intervention: Endoscopic sphincterotomy (EST) and endoscopic naso-bile drainage (ENBD)
Number of subjects: 90
Study 11384090 — intervention group
Group type: EXPERIMENTAL
Intervention: 105AD7
Number of subjects: 162
Study 11384090 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 162
Study 9421109 — intervention group
Group type: EXPERIMENTAL
Intervention: Rifampin with ascorbic acid
Number of subjects: 0
Study 9421109 — intervention group
Group type: COMPARATOR
Intervention: Rifampin without ascorbic acid
Number of subjects: 0
Study 8217599 — intervention group
Group type: EXPERIMENTAL
Intervention: 4‐HPR (N‐(4‐hydroxyphenyl) retinamide)
Number of subjects: 0
Study 8217599 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 3305118 — intervention group
Group type: EXPERIMENTAL
Intervention: Colloidal bismuth subcitrate (CBS) 120 mg daily
Number of subjects: 28
Study 3305118 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 28
Study 28807738 — intervention group
Group type: EXPERIMENTAL
Intervention: Aflibercept plus FOLFIRI
Number of subjects: 1226
Study 28807738 — intervention group
Group type: COMPARATOR
Intervention: Placebo plus FOLFIRI
Number of subjects: 1226
Study 27385730 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental group (teachers trained to be more autonomy supportive and less controlling)
Number of subjects: 1017
Study 27385730 — intervention group
Group type: COMPARATOR
Intervention: Control group (teachers not receiving the intervention)
Number of subjects: 1017
Study 27385730 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental group
Number of subjects: 1017
Study 23072444 — intervention group
Group type: EXPERIMENTAL
Intervention: Working in construction
Number of subjects: 8316
Study 23072444 — intervention group
Group type: EXPERIMENTAL
Intervention: Working in mining
Number of subjects: 8316
Study 23072444 — intervention group
Group type: EXPERIMENTAL
Intervention: Working in agriculture
Number of subjects: 8316
Study 23072444 — intervention group
Group type: EXPERIMENTAL
Intervention: Working in industry
Number of subjects: 8316
Study 23072444 — intervention group
Group type: EXPERIMENTAL
Intervention: Working in trade
Number of subjects: 8316
Study 23072444 — intervention group
Group type: EXPERIMENTAL
Intervention: Working in other services
Number of subjects: 8316
Study 23072444 — intervention group
Group type: EXPERIMENTAL
Intervention: Working in transport
Number of subjects: 8316
Study 23072444 — intervention group
Group type: EXPERIMENTAL
Intervention: Perception of neighbourhood security (third quartile of insecurity)
Number of subjects: 8316
Study 21209232 — intervention group
Group type: EXPERIMENTAL
Intervention: Clopidogrel (300 mg on the first day, then 75 mg once daily for 6 days)
Number of subjects: 13
Study 21209232 — intervention group
Group type: COMPARATOR
Intervention: Sibutramine (15 mg oral dose)
Number of subjects: 13
Study 19591674 — intervention group
Group type: EXPERIMENTAL
Intervention: Active PEMF-treatment for 60 days, four hours daily
Number of subjects: 68
Study 19591674 — intervention group
Group type: COMPARATOR
Intervention: Sham-treatment for 60 days, four hours daily
Number of subjects: 68
Study 16836628 — intervention group
Group type: EXPERIMENTAL
Intervention: Collaborative care intervention for depression
Number of subjects: 329
Study 16836628 — intervention group
Group type: COMPARATOR
Intervention: Usual primary care
Number of subjects: 329
Study 12638773 — intervention group
Group type: EXPERIMENTAL
Intervention: 3% hydrogen peroxide tooth-whitening gel
Number of subjects: 65
Study 12638773 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 65
Study 10721386 — intervention group
Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study 9262801 — intervention group
Group type: EXPERIMENTAL
Intervention: Midazolam (0.2 mg/kg)
Number of subjects: 10
Study 9262801 — intervention group
Group type: COMPARATOR
Intervention: Meperidine (2.0 mg/kg)/Promethazine (1.0 mg/kg)
Number of subjects: 10
Study 8331703 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose heparin
Number of subjects: 395
Study 8331703 — intervention group
Group type: EXPERIMENTAL
Intervention: Sequential compression devices
Number of subjects: 395
Study 8331703 — intervention group
Group type: COMPARATOR
Intervention: Low-dose heparin and Sequential compression devices
Number of subjects: 395
Study 8331703 — intervention group
Group type: COMPARATOR
Intervention: Patients with spinal injuries
Number of subjects: 395
Study 8331703 — intervention group
Group type: COMPARATOR
Intervention: Patients with severe head injuries
Number of subjects: 395
Study 3581737 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefoperazone (1 g)
Number of subjects: 929
Study 3581737 — intervention group
Group type: COMPARATOR
Intervention: Cefotaxime (1 g)
Number of subjects: 929
Study 29551181 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-use pre-filled flush syringes
Number of subjects: 48
Study 29551181 — intervention group
Group type: COMPARATOR
Intervention: Manually prepared syringes
Number of subjects: 48
Study 27174549 — intervention group
Group type: EXPERIMENTAL
Intervention: Uniportal video‐assisted lobectomy
Number of subjects: 106
Study 27174549 — intervention group
Group type: COMPARATOR
Intervention: Other video‐assisted thoracoscopic lobectomy techniques
Number of subjects: 106
Study 25549656 — intervention group
Group type: EXPERIMENTAL
Intervention: NMES robot group (n = 11)
Number of subjects: 26
Study 25549656 — intervention group
Group type: COMPARATOR
Intervention: robot group (n = 15)
Number of subjects: 26
Study 23043721 — intervention group
Group type: EXPERIMENTAL
Intervention: PRO+LEU (20 g casein protein + 2.5 g crystalline leucine)
Number of subjects: 24
Study 23043721 — intervention group
Group type: COMPARATOR
Intervention: PRO (20 g casein protein)
Number of subjects: 24
Study 23043721 — intervention group
Group type: EXPERIMENTAL
Intervention: PRO+LEU
Number of subjects: 24
Study 19756888 — intervention group
Group type: EXPERIMENTAL
Intervention: MIS-TKR
Number of subjects: 100
Study 18223530 — intervention group
Group type: EXPERIMENTAL
Intervention: 4 mg of dexamethasone
Number of subjects: 30
Study 18223530 — intervention group
Group type: EXPERIMENTAL
Intervention: 8 mg of dexamethasone
Number of subjects: 30
Study 22156381 — intervention group
Group type: EXPERIMENTAL
Intervention: Zoledronic acid (ZOL) 4 mg i.v. every 6 months for 2 years
Number of subjects: 90
Study 22156381 — intervention group
Group type: COMPARATOR
Intervention: Letrozole (2.5 mg/day) without ZOL
Number of subjects: 90
Study 15950351 — intervention group
Group type: EXPERIMENTAL
Intervention: Olanzapine in monotherapy (OGm)
Number of subjects: 724
Study 15950351 — intervention group
Group type: COMPARATOR
Intervention: Conventional antipsychotics (CG)
Number of subjects: 724
Study 12558013 — intervention group
Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study 9649102 — intervention group
Group type: EXPERIMENTAL
Intervention: Thermal uterine balloon therapy
Number of subjects: 255
Study 9649102 — intervention group
Group type: COMPARATOR
Intervention: Hysteroscopic rollerball ablation
Number of subjects: 255
Study 7977519 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical intravaginal clindamycin (dosages not specified, administered twice daily for 5 days)
Number of subjects: 33
Study 7977519 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 33
Study 3289300 — intervention group
Group type: EXPERIMENTAL
Intervention: Pirenzepine 50 mg
Number of subjects: 21
Study 3289300 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21
Study 31600796 — intervention group
Group type: EXPERIMENTAL
Intervention: Intact umbilical cord milking (UCM)
Number of subjects: 0
Study 31600796 — intervention group
Group type: COMPARATOR
Intervention: Immediate cord clamping (ICC)
Number of subjects: 0
Study 29139142 — intervention group
Group type: EXPERIMENTAL
Intervention: Levothyroxine sodium (0.044 mg/kg, 0.132 mg/kg, 0.22 mg/kg)
Number of subjects: 32
Study 29139142 — intervention group
Group type: EXPERIMENTAL
Intervention: Levothyroxine sodium (10× the labeled starting dose)
Number of subjects: 32
Study 29139142 — intervention group
Group type: EXPERIMENTAL
Intervention: Levothyroxine sodium (up to 10× the labeled starting dose)
Number of subjects: 32
Study 29139142 — intervention group
Group type: COMPARATOR
Intervention: Sham-dose (0×)
Number of subjects: 32
Study 28320484 — intervention group
Group type: EXPERIMENTAL
Intervention: Twice-daily intervention nutritional drink enriched with additional micronutrients, myo-inositol, and probiotics.
Number of subjects: 1800
Study 28320484 — intervention group
Group type: COMPARATOR
Intervention: Twice-daily control nutritional drink enriched with standard micronutrients.
Number of subjects: 1800
Study 26214765 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical treatment
Number of subjects: 102
Study 26214765 — intervention group
Group type: COMPARATOR
Intervention: Medical treatment
Number of subjects: 102
Study 23863230 — intervention group
Group type: EXPERIMENTAL
Intervention: Early goal-directed sedation
Number of subjects: 37
Study 23863230 — intervention group
Group type: COMPARATOR
Intervention: Standard sedation
Number of subjects: 37
Study 20620495 — intervention group
Group type: EXPERIMENTAL
Intervention: CsAm (Cyclosporine Minimization)
Number of subjects: 207
Study 20620495 — intervention group
Group type: COMPARATOR
Intervention: CsAe (Cyclosporine Elimination)
Number of subjects: 207
Study 18260770 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous glucose monitoring
Number of subjects: 0
Study 17342882 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluid intake at 8, 16, 24, and 32 kilometers (Early Trials)
Number of subjects: 7
Study 17342882 — intervention group
Group type: COMPARATOR
Intervention: Fluid intake at 10, 20, 30, and 40 kilometers (Late Trials)
Number of subjects: 7
Study 14663127 — intervention group
Group type: EXPERIMENTAL
Intervention: Microscopists' readings of low grade NGU slides (5-20 p/hpf)
Number of subjects: 60
Study 14663127 — intervention group
Group type: EXPERIMENTAL
Intervention: Microscopists' readings of high grade NGU slides (>20 p/hpf)
Number of subjects: 60
Study 14663127 — intervention group
Group type: EXPERIMENTAL
Intervention: Microscopists' readings of negative slides (<5 p/hpf)
Number of subjects: 60
Study 14663127 — intervention group
Group type: EXPERIMENTAL
Intervention: Repeat readings by the same microscopist for negative slides
Number of subjects: 60
Study 14663127 — intervention group
Group type: EXPERIMENTAL
Intervention: Repeat readings by the same microscopist for low grade slides
Number of subjects: 60
Study 14663127 — intervention group
Group type: EXPERIMENTAL
Intervention: Repeat readings by the same microscopist for high grade slides
Number of subjects: 60
Study 10962167 — intervention group
Group type: EXPERIMENTAL
Intervention: Artificial sweetener (10 parts cyclamate and 1 part saccharin)
Number of subjects: 80
Study 10962167 — intervention group
Group type: EXPERIMENTAL
Intervention: Glycine (sweet amino acid)
Number of subjects: 80
Study 10962167 — intervention group
Group type: EXPERIMENTAL
Intervention: Breast milk
Number of subjects: 80
Study 10962167 — intervention group
Group type: COMPARATOR
Intervention: Placebo (water)
Number of subjects: 80
Study 8869604 — intervention group
Group type: EXPERIMENTAL
Intervention: Partial inferior turbinectomy (PIT)
Number of subjects: 52
Study 8869604 — intervention group
Group type: COMPARATOR
Intervention: Cryosurgery (CS)
Number of subjects: 52
Study 1500966 — intervention group
Group type: EXPERIMENTAL
Intervention: Composite resin restorative material (Heliomolar R.O.)
Number of subjects: 104
Study 1500966 — intervention group
Group type: COMPARATOR
Intervention: Amalgam alloy restorations
Number of subjects: 104
Study 6100488 — intervention group
Group type: EXPERIMENTAL
Intervention: Nifedipine (20 mg sublingually)
Number of subjects: 5
Study 6100488 — intervention group
Group type: EXPERIMENTAL
Intervention: Nifedipine (10 mg sublingually)
Number of subjects: 5
Study 6100488 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 5
Study 28892807 — intervention group
Group type: EXPERIMENTAL
Intervention: Osteopathic Intervention (OI)
Number of subjects: 50
Study 28892807 — intervention group
Group type: EXPERIMENTAL
Intervention: General Osteopathic Treatment (GOT)
Number of subjects: 50
Study 28892807 — intervention group
Group type: COMPARATOR
Intervention: Control Group (untreated)
Number of subjects: 50
Study 27730033 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 mg daily isotretinoin (Group A)
Number of subjects: 240
Study 27730033 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 mg alternate days isotretinoin (Group B)
Number of subjects: 240
Study 24730718 — intervention group
Group type: EXPERIMENTAL
Intervention: Negative affect
Number of subjects: 0
Study 24730718 — intervention group
Group type: COMPARATOR
Intervention: Neutral affect
Number of subjects: 0
Study 23853000 — intervention group
Group type: EXPERIMENTAL
Intervention: MenC-CRM glycoconjugate vaccine (CRM-group)
Number of subjects: 124
Study 23853000 — intervention group
Group type: EXPERIMENTAL
Intervention: Bivalent meningococcal serogroup A/C polysaccharide vaccine (PS-group)
Number of subjects: 124
Study 23853000 — intervention group
Group type: COMPARATOR
Intervention: No additional doses of MenC vaccine (control group)
Number of subjects: 124
Study 20079691 — intervention group
Group type: EXPERIMENTAL
Intervention: Anthracycline treatment
Number of subjects: 1762
Study 20079691 — intervention group
Group type: COMPARATOR
Intervention: Control (no anthracycline treatment)
Number of subjects: 1762
Study 19107254 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonmyeloablative stem cell transplantation (NST)
Number of subjects: 34
Study 19107254 — intervention group
Group type: COMPARATOR
Intervention: Myeloablative HSCT
Number of subjects: 34
Study 19107254 — intervention group
Group type: EXPERIMENTAL
Intervention: Both NST and myeloablative HSCT
Number of subjects: 34
Study 17115520 — intervention group
Group type: EXPERIMENTAL
Intervention: Modelling group (expert- and self-modelling, performance feedback)
Number of subjects: 16
Study 17115520 — intervention group
Group type: COMPARATOR
Intervention: Control group (no feedback)
Number of subjects: 16
Study 15164106 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.2 g/day nonesterified, nonhydrogenated plant sterols in low-fat milk (Lo)
Number of subjects: 81
Study 15164106 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.6 g/day nonesterified, nonhydrogenated plant sterols in low-fat milk (Hi)
Number of subjects: 81
Study 15164106 — intervention group
Group type: COMPARATOR
Intervention: 0 g/day nonesterified, nonhydrogenated plant sterols in low-fat milk (C)
Number of subjects: 81
Study 11495184 — intervention group
Group type: EXPERIMENTAL
Intervention: Coeducational prevention program for teenagers on sexual coercion, including communication skills training and enhanced instruction via video and interactive video 'virtual date'.
Number of subjects: 458
Study 11495184 — intervention group
Group type: COMPARATOR
Intervention: Control condition (not specified).
Number of subjects: 458
Study 9430755 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical anesthetic
Number of subjects: 202
Study 9430755 — intervention group
Group type: EXPERIMENTAL
Intervention: Vasoconstrictor
Number of subjects: 202
Study 9430755 — intervention group
Group type: EXPERIMENTAL
Intervention: Placebo
Number of subjects: 202
Study 9430755 — intervention group
Group type: COMPARATOR
Intervention: No treatment
Number of subjects: 202
Study 8297301 — intervention group
Group type: EXPERIMENTAL
Intervention: Tapes
Number of subjects: 68
Study 8297301 — intervention group
Group type: COMPARATOR
Intervention: Staples
Number of subjects: 68
Study 8297301 — intervention group
Group type: COMPARATOR
Intervention: Interrupted nylon sutures
Number of subjects: 68
Study 15791754 — intervention group
Group type: EXPERIMENTAL
Intervention: CATI
Number of subjects: 0
Study 15791754 — intervention group
Group type: COMPARATOR
Intervention: non-CATI
Number of subjects: 0
Study 31810389 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin glargine
Number of subjects: 1170
Study 31810389 — intervention group
Group type: EXPERIMENTAL
Intervention: Lixisenatide (added to iGlar)
Number of subjects: 1170
Study 31810389 — intervention group
Group type: EXPERIMENTAL
Intervention: iGlarLixi
Number of subjects: 1170
Study 29444672 — intervention group
Group type: EXPERIMENTAL
Intervention: Mediterranean diet
Number of subjects: 41
Study 29444672 — intervention group
Group type: COMPARATOR
Intervention: Low-fat diet
Number of subjects: 41
Study 27130844 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline plasma concentrations of VEGF above cohort median
Number of subjects: 503
Study 27130844 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline plasma concentrations of sVEGFR1 above cohort median
Number of subjects: 503
Study 27130844 — intervention group
Group type: EXPERIMENTAL
Intervention: Membranous c‐Met protein levels
Number of subjects: 503
Study 27130844 — intervention group
Group type: EXPERIMENTAL
Intervention: Genomic DNA sequencing of cancer-related genes
Number of subjects: 503
Study 24690184 — intervention group
Group type: EXPERIMENTAL
Intervention: Healthy Activity Program for moderate to severe depression plus enhanced usual care
Number of subjects: 900
Study 24690184 — intervention group
Group type: EXPERIMENTAL
Intervention: Counselling for Alcohol Problems for harmful and dependent drinking plus enhanced usual care
Number of subjects: 900
Study 24690184 — intervention group
Group type: COMPARATOR
Intervention: Enhanced usual care only
Number of subjects: 900
Study 23579892 — intervention group
Group type: EXPERIMENTAL
Intervention: GC Fuji II LC
Number of subjects: 80
Study 23579892 — intervention group
Group type: EXPERIMENTAL
Intervention: Caviton
Number of subjects: 80
Study 23579892 — intervention group
Group type: EXPERIMENTAL
Intervention: GC Fuji IX
Number of subjects: 80
Study 23579892 — intervention group
Group type: EXPERIMENTAL
Intervention: Kalzinol
Number of subjects: 80
Study 20685303 — intervention group
Group type: EXPERIMENTAL
Intervention: Naturally occurring diterpenes such as forskolin and stevioside
Number of subjects: 0
Study 18603398 — intervention group
Group type: EXPERIMENTAL
Intervention: Amoxicillin and ambroxol hydrochloride tablets
Number of subjects: 0
Study 16619181 — intervention group
Group type: EXPERIMENTAL
Intervention: Towne/Toledo chimeric vaccine
Number of subjects: 20
Study 16619181 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 14971151 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined therapy including adaptation to intermittent normobaric hypoxia and medicines
Number of subjects: 62
Study 14971151 — intervention group
Group type: COMPARATOR
Intervention: Drugs alone (control group)
Number of subjects: 62
Study 10406244 — intervention group
Group type: COMPARATOR
Intervention: H. pylori infection assessment using culture growth, histological tests, and CLOtest results.
Number of subjects: 2394
Study 7588666 — intervention group
Group type: EXPERIMENTAL
Intervention: 6 microliters 0.25% bupivacaine + 0.05 mg kg‐1 midazolam
Number of subjects: 30
Study 7588666 — intervention group
Group type: COMPARATOR
Intervention: 6 microliters 0.25% bupivacaine
Number of subjects: 30